DEMENTIA TRIALS AUSTRALIA

Month: March 2020

Home 2020 March

Biogen

Taryn Wills
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease (TANGO). Status: Active Sponsor: Biogen More info

ImmuneBio

Taryn Wills
A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's Status: Recruiting Sponsor: ImmuneBio More info

Cognition Therapeutics

Taryn Wills
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. Status: Recruiting Sponsor: Cognition Therapeutics More info

ANAVEX Australia Pty Limited

Taryn Wills
A Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy trial of ANAVEX2-73 for the Treatment of Early Alzheimer’s disease (AD) Status: Recruiting Sponsor: ANAVEX Australia Pty Limited More info
Menu